The Latest

David Alain Wohl recaps CROI 2021 research during a video interview

CROI 2021 Highlights: New HIV Research With Clinical Impact

Here's a walkthrough of some of the most compelling stories coming out of the year's biggest HIV science meeting to date.

By Myles Helfand
photo of David Alain Wohl, M.D., as he recaps research from CROI 2021

Sleep and Diet: Don’t Underestimate Their Importance for People Living With HIV

David Alain Wohl, M.D., on new findings from CROI 2021 that help us better understand the connections between sleep, diet, and quality of life among people living with HIV.

By David Alain Wohl, M.D.
photo of David Alain Wohl, M.D., as he recaps research from CROI 2021

Hypertension Control Emerges as Key Concern in Examination of HIV, Aging, and Cardiovascular Disease

David Alain Wohl, M.D., talks through new data presented at CROI 2021 that further our understanding of the interplay between HIV and comorbidities we often associate with aging, particularly those related to cardiovascular disease.

By David Alain Wohl, M.D.
photo of David Alain Wohl, M.D., as he recaps COVID-19 research from CROI 2021

HIV & COVID-19: CROI 2021 Reveals New Research

David Alain Wohl, M.D., analyzes updated data regarding the intersection of HIV and COVID-19, with a particular focus on SARS-CoV-2 susceptibility and disease severity.

By David Alain Wohl, M.D.

Anal Cancer Screening Must Include Women Living With HIV, Researchers Say

The incidence of anal cancer is rapidly growing in the United States, and may overtake cervical cancer within the next 10 years.

By Terri Wilder, M.S.W.
Screenshot from CROI 2021 oral abstract session on complications of HIV and COVID-19

CROI 2021 Data Bites: HIV and COVID-19

There's new research on the risk of severe COVID-19 among people living with HIV, as well as prevention and treatment options.

By Larry Buhl and Myles Helfand
video conference

This Week in HIV Research: While You Were CROI-ing

March 11, 2021: Anticholinergic medications and neurocognitive issues; weight gain and dolutegravir in older men; drug interaction risks on B/F/TAF; real-world efficacy of HBV-active HIV treatment.

By Barbara Jungwirth and Myles Helfand
Screenshot from CROI 2021 oral abstract session on HIV complications

CROI 2021 Data Bites: HIV-Related Complications and Comorbidities

Newly reported research includes deep dives into many health issues commonly experienced by people living with HIV, including cancer, cardiovascular disease, depression/anxiety, and metabolic disorders.

By Myles Helfand and Larry Buhl
CROI 2019

New COVID-19 Research and HIV Intervention Breakthroughs Are on the Menu at CROI 2021

Arriving on the one-year anniversary of nationwide COVID-19 shutdowns, the 2021 Conference on Retroviruses and Opportunistic Infections won't be in person this year—but it will emphasize COVID-19 alongside important HIV prevention and treatment updates.

By Larry Buhl
doctor on telephone

How a Midwestern HIV Clinic Rapidly Adjusted to the Spreading COVID-19 Pandemic

At the University of Nebraska Medical Center, HIV care providers scrambled to set up new systems in hopes of maintaining retention in care and viral suppression among as many patients as possible.

By Larry Buhl